International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377


International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 51

PDF Downloaded: 46

Manjunatha, Damera, Kumar T K, Chandini, Popat, and Vala: Novel Albumin Gel-platelet-rich fibrin mixture (Alb-PRF); where do we stand?


A variety of surgical procedures, biomaterials, and growth factors have been used in regenerative dentistry in either hard or soft tissues generation acceleration. While there has been significant progress in the utilization of biological agents as essential mediators of tissue regeneration, numerous drawbacks have been highlighted, including high costs and the possibility of inflammation.1, 2, 3 Nonetheless, biological agents such as recombinant human platelet-derived growth factor (rhPDGF) and bone morphogenetic protein-2 (rhBMP2) play critical roles in modern medicine for the regeneration of complicated abnormalities. Autologous platelet concentrates have also gained popularity in recent years as a low-cost restorative therapy capable of stimulating tissue neoangiogenesis.4, 5, 6

Platelet-rich plasma (PRP) was considered as a denovo-inception of platelet analogs that panders & also increases the platelet concentrations by sextuple to octaple.7, 8, 9 Early tests demonstrated that numerous essential growth factors contained in blood, such as PDGF, TGF-1, and VEGF, may be detected in greater units when compared to whole blood, favoring regulation of tissue regeneration and wound healing.10, 11, 12, 13, 14, 15

Platelet-rich fibrin (PRF) has recently been proposed as a platelet concentrate generated from whole blood without the use of anticoagulants.16, 17 Following centrifugation, PRF forms a fibrin clot and can be used as a regenerative agent with appropriate units of host platelets and leukocytes as well as autologous growth factors. Furthermore, modifications to protocols as well as centrifugation tubes have further allowed for a working liquid-PRF that may be utilized as an injectable modality similar to PRP.18

History of Alb-PRF

One of the most significant disadvantages of PRF has been it’s low in vivo turnover rate. The ability to act as a true barrier is limited, in regenerative dentistry because it is associated with a typical 10-14-day resorption period in vivo.19 Kawase et al. presented an intriguing attempt to use the heat-compression technique with PRF membranes for guide tissue regeneration (GTR) treatment. The heat-compressed PRF was observed for at least 3 weeks postimplantation in vivo, whereas the control PRF membranes, were completely resorbed within 2 weeks.19

Furthermore, in facial aesthetics and plastic surgery, a novel technique was developed in which platelet-poor plasma (PPP) containing roughly 60 percent albumin is heated at 75 degrees Celsius for 10 minutes to allow for the denaturation and breaking of many of the weak linkages or bonds (e.g. electrovalent bonds like H2) within its protein molecule20 in the aftermath, the proteins are redeployed into a highly compact protein-packed structure with prolonged resorption characteristics lasting up to 4–6 months.20, 21

However, despite the longer-lasting heat-treated PRF/PPP, a poorer regeneration capacity is to be predicted, because no cells/growth factors in the heat-treated PRF/PPP can withstand the denaturation process (thermal heating). For these reasons, a technique known as Alb-PRF involves reintroducing the platelet-rich layer from the buffy coat into heated PPP (albumin gel) after cooling.22 (Figure 1)

Figure 1

Recent Extensive Literature Regarding AlbPRF

Platelet-rich fibrin (PRF) has been proposed as an autologous membrane with the advantages of host platelet and leukocyte accumulation as well as growth factor entrapment. The impediment of this is its rapid degradation properties (2 weeks). Interestingly, recent research has shown that heating a liquid platelet-poor plasma (PPP) layer can prolong the resorption characteristics from 2 weeks to more than 4 months (e-PRF) of heated albumin (albumin gel) Masako Fujioka-Kobayashi et al. set out to characterize the biological features of this unique regeneration mode. In nine-milliliter polypropylene tubes, whole blood was centrifuged at 700 g for 8 minutes. Following that, the denatured albumin (albumin gel) was obtained by tempering the platelet-poor plasma layer for 10 minutes at 75° C, to produce. Subsequently, the residual cells and the growth factor detected in the buffy coat (liquid PRF) were again mixed with the cooled albumin gel, to form AlbPRF.23

A histological investigation was then performed, including cell distribution within AlbPRF. The kinetics of seven distinct growth factors, including PDGF-AA, PDGF-AB, PDGF-BB, TGF-1, VEGF, IGF, and EGF, were studied in AlbPRF for up to 10 days. Following that, gingival fibroblast cell responses to Alb-PRF were studied using a live/dead test at 24 hours, a migration assay at 24 hours, a proliferation assay at 1, 3, and 5 days, real-time PCR for TGF- and collagen 1a2 expression at 3 and 7 days, and collagen 1 immunostaining at 14 days. Histological examination revealed that living cells were also dispersed throughout the AlbPRF formulation. Throughout the 10 days, growth factor release was sluggish and progressive, notably for TGF-1 and PDGF-AA/AB. When compared to control TCP, Alb-PRF had statistically considerably, higher cell biocompatibility at 24 hours and statistically significantly higher fibroblast proliferation at 5 days. AlbPRF also caused statistically significant increases in TGF mRNA levels, at 3 and 7 days, as well as in collagen mRNA levels at 1 to 7 days.23


The current findings suggest that AlbPRF has regeneration characteristics that are caused by the slow and steady release of growth factors contained in liquid PRF via albumin gel breakdown. Future research is needed to thoroughly define the degrading features of Alb-PRF in vivo and to investigate potential therapeutic uses in other domains of medicine.

Source of Funding


Conflict of Interest

The authors declare no conflict of interest.



O Anusaksathien WV Giannobile Growth factor delivery to re-engineer periodontal tissuesCurr Pharm Biotechnol2002321293910.2174/1389201023378391


AC Carreira FH Lojudice E Halcsik RD Navarro MC Sogayar JM Granjeiro Bone morphogenetic proteins: facts, challenges, and future perspectivesJ Dent Res201493433545


BG Rocque MP Kelly JH Miller Y Li PA Anderson Bone morphogenetic protein-associated complications in pediatric spinal fusion in the early postoperative period: an analysis of 4658 patients and review of the literatureJ Neurosurg Pediatr20141466354310.3171/2014.8.peds13665


AB Castro N Meschi A Temmerman N Pinto P Lambrechts W Teughels Regenerative potential of leucocyte-and platelet-rich fibrin. Part A: intra-bony defects, furcation defects, and periodontal plastic surgery. A systematic review and meta-analysisJ Clin Periodontol2017441678210.1111/jcpe.12643


AB Castro N Meschi A Temmerman N Pinto P Lambrechts W Teughels Regenerative potential of leucocyte and platelet-rich fibrin. Part B: sinus floor elevation, alveolar ridge preservation, and implant therapy. A systematic reviewJ Clin Periodontol20174422253410.1111/jcpe.12658


RJ Miron G Zucchelli MA Pikos M Salama S Lee V Guillemette Use of platelet-rich fibrin in regenerative dentistry: a systematic reviewClin Oral Investig201721619132710.1007/s00784-017-2133-z5


RE Marx Platelet-rich plasma (PRP): what is PRP and what is not PRP?Implant Dent2001104225810.1097/00008505-200110000-00002


RE Marx Platelet-rich plasma: evidence to support its useJ Oral Maxillofac Surg20046244899610.1016/j.joms.2003.12.003


RE Marx ER Carlson RM Eichstaedt SR Schimmele JE Strauss KR Georgeff Platelet-rich plasma: growth factor enhancement for bone graftsOral Surg Oral Med Oral Pathol Oral Radiol Endod19988566384610.1016/s1079-2104(98)90029-4


I Medina-Porqueres P Alvarez-Juarez The efficacy of platelet-rich plasma injection in the management of hip osteoarthritis: a systematic review protocolMusculoskeletal Care201510.1002/msc.11151


F Salamanna F Veronesi M Maglio ED Bella New and emerging strategies in platelet-rich plasma application in musculoskeletal regenerative procedures: general overview on still open questions and outlookBiomed Res Int2015201584604510.1155/2015/846045


A Albanese ME Licata B Polizzi G Campisi Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regenerationImmun Ageing2013102310.1186/1742-4933-10-23


DMD Ehrenfest I Andia MA Zumstein CQ Zhang NR Pinto T Bielecki Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectivesMuscles Ligaments Tendons J201443910.32098/mltj.01.2014.02


P Maney M Amornporncharoen A Palaiologou Applications of plasma rich in growth factors (PRGF) in dental surgery: a reviewJ West Soc Periodontol Periodontal Abstr201361499104


S Panda J Doraiswamy S Malaiappan SS Varghese MD Fabbro Additive effect of autologous platelet concentrates in treatment of intrabony defects: a systematic review and meta-analysisJ Investig Clin Dent2016711326


J Choukroun A Diss A Simonpieri MO Girard C Schoeffler SL Dohan Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part V: histologic evaluations of PRF effects on bone allograft maturation in sinus liftOral Surg Oral Med Oral Pathol Oral Radiol Endod2006101329930310.1016/j.tripleo.2005.07.012


DM Dohan J Choukroun A Diss SL Dohan AJ Dohan J Mouhyi Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic featuresOral Surg Oral Med Oral Pathol Oral Radiol Endod20061013e455010.1016/j.tripleo.2005.07.009


RJ Miron M Fujioka-Kobayashi M Hernandez U Kandalam Y Zhang S Ghanaati Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry?Clin Oral Investig201721826192710.1007/s00784-017-2063-9


T Kawase M Kamiya M Kobayashi T Tanaka K Okuda LF Wolff The heat-compression technique for the conversion of platelet-rich fibrin preparation to a barrier membrane with a reduced rate of biodegradationJ Biomed Mater Res B Appl Biomater20151038253110.1002/jbm.b.33262


C Mourão E Gheno ES Lourenço RDL Barbosa GM Kurtzman K Javid Characterization of a new membrane from concentrated growth factors associated with denaturized Albumin (Alb-CGF) for clinical applications: A preliminary studyInt J Growth Factors Stem Cells Dent201816410.4103/GFSC.GFSC_21_18


SY Jung HY Kim HJ Oh E Choi MS Cho HS Kim Feasibility of autologous plasma gel for tonsil-derived stem cell therapeutics in hypoparathyroidismSci Rep201881189610.1038/s41598-018-30454-1


NN Doghaim RA El-Tatawy YME Neinaa Assessment of the efficacy and safety of platelet poor plasma gel as autologous dermal filler for facial rejuvenationJ Cosmet Dermatol2019181271127910.1111/jocd.12876


M Fujioka-Kobayashi B Schaller CFAB Mourão Y Zhang A Sculean R J Miron Biological characterization of an injectable platelet-rich fibrin mixture consisting of autologous albumin gel and liquid platelet-rich fibrin (Alb-PRF)Platelets2021321748110.1080/09537104.2020.1717455


© This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Article type

Review Article

Article page


Authors Details

Vinayaka Ambujakshi Manjunatha*, Trinath Kishore Damera, Akshay Kumar T K, Velicheti Sai Chandini, Tanmay Popat, Devanshi Vala

Article History

Received : 18-11-2021

Accepted : 27-12-2021

Available online : 11-01-2022

Article Metrics

View Article As


Downlaod Files


Open Abstract (Increase article citation) Wiki in hindi